rs2287692

Variant names:

• chr19-40783851-G-A
• rs2287692
• NM_016154.5:c.275+11G>A

Your query was ambiguous. Multiple possible variants found:

• chr19-40783851-G-A
• chr19-40783851-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_016154.5(RAB4B):​c.275+11G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.14 in 1,569,146 control chromosomes in the GnomAD database, including 16,435 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: 𝑓 0.11 (1151 hom., cov: 30)
  • Exomes 𝑓: 0.14 (15284 hom.)
• Consequence: RAB4B NM_016154.5 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.601
• Publications: 13 publications found

Genes affected

RAB4B (HGNC:9782): (RAB4B, member RAS oncogene family) Predicted to enable G protein activity and GTP binding activity. Involved in glucose import. Located in insulin-responsive compartment; perinuclear region of cytoplasm; and recycling endosome. [provided by Alliance of Genome Resources, Apr 2022]

RAB4B-EGLN2 (HGNC:44465): (RAB4B-EGLN2 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring RAB4B (RAB4B, member RAS oncogene family) and EGLN2 (egl nine homolog 2) genes on chromosome 19. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

MIA-RAB4B (HGNC:48352): (MIA-RAB4B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring MIA (melanoma inhibitory activity) and RAB4B (RAB4B, member RAS oncogene family) genes on chromosome 19. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is therefore unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

ENSG00000282951 (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.83).
• BA1: GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.165 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016154.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	RAB4B	NM_016154.5	MANE Select	c.275+11G>A		intron	N/A	NP_057238.3
	MIA-RAB4B	NR_037775.1		n.637+11G>A		intron	N/A
	RAB4B-EGLN2	NR_037791.1		n.432+11G>A		intron	N/A

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	RAB4B	ENST00000357052.8	TSL:1 MANE Select	c.275+11G>A		intron	N/A	ENSP00000349560.2	P61018-1
	RAB4B	ENST00000378307.9	TSL:1	n.275+11G>A		intron	N/A	ENSP00000367557.4	F6SQB9
	RAB4B-EGLN2	ENST00000594136.2	TSL:2	n.275+11G>A		intron	N/A	ENSP00000469872.1

Frequencies

GnomAD3 genomes AF: 0.109 AC: 16495 AN: 151618 Hom.: 1148 Cov.: 30

Gnomad AFR AF: 0.0334

Gnomad AMI AF: 0.0329

Gnomad AMR AF: 0.132

Gnomad ASJ AF: 0.117

Gnomad EAS AF: 0.0748

Gnomad SAS AF: 0.174

Gnomad FIN AF: 0.135

Gnomad MID AF: 0.117

Gnomad NFE AF: 0.144

Gnomad OTH AF: 0.108

GnomAD2 exomes AF: 0.135 AC: 29932 AN: 221640 AF XY: 0.140

Gnomad AFR exome AF: 0.0307

Gnomad AMR exome AF: 0.163

Gnomad ASJ exome AF: 0.111

Gnomad EAS exome AF: 0.0703

Gnomad FIN exome AF: 0.140

Gnomad NFE exome AF: 0.142

Gnomad OTH exome AF: 0.130

GnomAD4 exome AF: 0.144 AC: 203498 AN: 1417412 Hom.: 15284 Cov.: 46 AF XY: 0.145 AC XY: 101309 AN XY: 699468

African (AFR) AF: 0.0293 AC: 957 AN: 32620

American (AMR) AF: 0.158 AC: 6462 AN: 40808

Ashkenazi Jewish (ASJ) AF: 0.110 AC: 2601 AN: 23642

East Asian (EAS) AF: 0.121 AC: 4697 AN: 38970

South Asian (SAS) AF: 0.182 AC: 14759 AN: 81104

European-Finnish (FIN) AF: 0.143 AC: 7415 AN: 52018

Middle Eastern (MID) AF: 0.116 AC: 619 AN: 5356

European-Non Finnish (NFE) AF: 0.146 AC: 158186 AN: 1084522

Other (OTH) AF: 0.134 AC: 7802 AN: 58372

GnomAD4 genome AF: 0.109 AC: 16507 AN: 151734 Hom.: 1151 Cov.: 30 AF XY: 0.110 AC XY: 8133 AN XY: 74130

African (AFR) AF: 0.0334 AC: 1385 AN: 41470

American (AMR) AF: 0.133 AC: 2022 AN: 15226

Ashkenazi Jewish (ASJ) AF: 0.117 AC: 406 AN: 3470

East Asian (EAS) AF: 0.0743 AC: 379 AN: 5098

South Asian (SAS) AF: 0.175 AC: 839 AN: 4792

European-Finnish (FIN) AF: 0.135 AC: 1420 AN: 10516

Middle Eastern (MID) AF: 0.126 AC: 37 AN: 294

European-Non Finnish (NFE) AF: 0.144 AC: 9765 AN: 67854

Other (OTH) AF: 0.107 AC: 224 AN: 2102

Alfa AF: 0.136 Hom.: 2298

Bravo AF: 0.102

Asia WGS AF: 0.118 AC: 413 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.83
CADD	Benign	5.4
DANN	Benign	0.75
PhyloP100		0.60
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs2287692; hg19: chr19-41289756; COSMIC: COSV63825188; COSMIC: COSV63825188;